All News #Library
Others
Alopexx to Present Data on F598, a Novel, Broad-Spectrum Immunotherapeutic
12 Oct 2023 //
PR NEWSWIRE
Alopexx Announces Presentation at IDWeek 2023
11 Oct 2023 //
PR NEWSWIRE

Market Place
Sourcing Support